Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
Florent Peyraud, Jean‐Philippe Guégan, Dominique Bodet, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Cellular metabolism regulates the differentiation and function of T-cell subsets
Sicong Ma, Yanan Ming, Jingxia Wu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 5, pp. 419-435
Open Access | Times Cited: 42
Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation
Baoyi Li, Menghang Zu, Aodi Jiang, et al.
Biomaterials (2024) Vol. 307, pp. 122530-122530
Closed Access | Times Cited: 20
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 39
Amino acid metabolism, redox balance and epigenetic regulation in cancer
Xiang Li, Hongsheng Zhang
FEBS Journal (2023) Vol. 291, Iss. 3, pp. 412-429
Open Access | Times Cited: 34
Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms
Yufei Liu, Zhangming Pei, Tong Pan, et al.
Microbiological Research (2023) Vol. 272, pp. 127392-127392
Open Access | Times Cited: 29
Metabolic engineering for optimized CAR-T cell therapy
Sarah McPhedran, Gillian Carleton, Julian J. Lum
Nature Metabolism (2024) Vol. 6, Iss. 3, pp. 396-408
Closed Access | Times Cited: 14
The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy
Brian D. Griffith, Timothy L. Frankel
Cancers (2024) Vol. 16, Iss. 3, pp. 472-472
Open Access | Times Cited: 8
Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer
Jing Yan, Di Chen, Zi Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Closed Access | Times Cited: 8
Cooperative Hedgehog/GLI and JAK/STAT signaling drives immunosuppressive tryptophan/kynurenine metabolism via synergistic induction of IDO1 in skin cancer
Dominik P. Elmer, Georg Stockmaier, Sandra Grund‐Gröschke, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Mechanism and strategies of immunotherapy resistance in colorectal cancer
Jiqi Shan, Dong Han, Chunyi Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
Yue Zheng, Yiran Yao, Tongxin Ge, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Metabolic interplay: tumor macrophages and regulatory T cells
Stefania Vilbois, Yingxi Xu, Ping‐Chih Ho
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 242-255
Closed Access | Times Cited: 20
Metabolites and Immune Response in Tumor Microenvironments
Salvatore Cortellino, Valter D. Longo
Cancers (2023) Vol. 15, Iss. 15, pp. 3898-3898
Open Access | Times Cited: 17
Polypyrrole/carbon dot nanocomposite as an electrochemical biosensor for liquid biopsy analysis of tryptophan in the human serum of normal and breast cancer women
Fatma A. M. Abdel‐aal, Rania M. Kamel, Asmaa Abdeltawab, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 415, Iss. 20, pp. 4985-5001
Open Access | Times Cited: 16
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer
Chunjing Wu, S. Spector, George Theodoropoulos, et al.
Cancer & Metabolism (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Is obstructive sleep apnea a circadian rhythm disorder?
Julija Šmon, Eva Kočar, Tadeja Pintar, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Open Access | Times Cited: 14
Differential Diagnosis of Urinary Cancers by Surface-Enhanced Raman Spectroscopy and Machine Learning
Li Song, Fei Xue, Tingmiao Li, et al.
Analytical Chemistry (2025) Vol. 97, Iss. 1, pp. 27-32
Closed Access
Metabolic Signaling in the Tumor Microenvironment
Ryan Clay, K Li, Lingtao Jin
Cancers (2025) Vol. 17, Iss. 1, pp. 155-155
Open Access
IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment
Zhaorong Wu, Hongye Wang, Zhigang Zheng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Physiological and pathophysiological effects of L-tryptophan’s metabolites on the brain and immunity – a challenge for drug development
Petar Iliev, Samuil Ivanov, S Lazarov, et al.
Pharmacia (2025) Vol. 72, pp. 1-7
Open Access
Recent developments in myeloid immune modulation in cancer therapy
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
TDO Target Inhibitor Research Progress Review
Yuxuan Han, Peng Wang, Zhaolin Guo, et al.
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 03, pp. 356-368
Open Access
A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top